Karen Drexler Elected to ResMed’s Board of Directors

Drexler brings experience serving with companies in the digital health, medical device and diagnostic markets.

Healthcare executive Karen Drexler is the newest member of ResMed’s Board of Directors.

With extensive management experience as a founder and CEO, and serving on the boards of public and private digital health, medical device, and diagnostic companies for over a decade, Drexler is the CEO and board member of Sandstone Diagnostics, a commercial-stage consumer diagnostics company.

“I’m thrilled to welcome Karen Drexler to ResMed’s Board,” said ResMed Founder and Board Chairman Peter Farrell. “Her deep expertise in advising and managing medical device, digital health and diagnostic companies, and particularly her experience in technology and out-of-hospital care models, will serve ResMed well as we continue to deepen our leadership in connected care and digital health.”

Also announced by ResMed was the retiring of Dr. Chris Roberts, who served on ResMed’s board for 25 years.

Drexler is a mentor and advisor with Astia, a global nonprofit focused on female founders. She is also a founding member of Astia Angels. Drexler also served as president and CEO of Amira Medical Inc. from 1996 until 2001. From 1984 to 1995, she held various positions at LifeScan.

Dr. Roberts served as CEO, president and board member of Cochlear Limited from 2004 to 2015.

About the Author

Joseph Duffy is a freelance writer and marketing consultant, and a regular contributor to HME Business and DME Pharmacy. He can be reached via e-mail at joe@prooferati.com.

HME Business Podcast